|
Mitjavila M, Jimenez-Fonseca P, Bello P, Pubul V, Percovich JC, Garcia-Burillo A, Hernando J, Arbizu J, Rodeno E, Estorch M, Llana B, Castellon M, Garcia-Canamaque L, Gajate P, Riesco MC, Miguel MB, Balaguer-Munoz D, Custodio A, Cano JM, Repetto A, Garcia-Alonso P, Muros MA, Vercher-Conejero JL, Carmona-Bayonas A. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2486-2500. doi: 10.1007/s00259-023-06166-8. Epub 2023 Mar 6. PubMed PMID: 36877234; PubMed Central PMCID: PMC10250456.
AÑO: 2023; IF: 8.6
|
36877234
|
Lee EM, Jimenez-Fonseca P, Carmona-Bayonas A, Hernandez R, Cruz-Castellanos P, Obispo B, Antonanzas-Basa M, Palacin-Lois M, Castillo-Trujillo OA, Calderon C. Clinicians' and Advanced Cancer Patients' Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment. Healthcare (Basel). 2023 Aug 7;11(15):2222. doi: 10.3390/healthcare11152222. PubMed PMID: 37570462; PubMed Central PMCID: PMC10419268.
AÑO: 2023; IF: 2.4
|
|
Capdevila J, Hernando J, Teule A, Lopez C, Garcia-Carbonero R, Benavent M, Custodio A, Garcia-Alvarez A, Cubillo A, Alonso V, Carmona-Bayonas A, Alonso-Gordoa T, Crespo G, Jimenez-Fonseca P, Blanco M, Viudez A, La Casta A, Sevilla I, Segura A, Llanos M, Landolfi S, Nuciforo P, Manzano JL. Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin. Nat Commun. 2023 May 23;14(1):2973. doi: 10.1038/s41467-023-38611-5. PubMed PMID: 37221181; PubMed Central PMCID: PMC10204675.
AÑO: 2023; IF: 14.7
|
|
Castillon JC, Gordoa TA, Bayonas AC, Carretero AC, Garcia-Carbonero R, Pulido EG, Fonseca PJ, Lete AL, Huerta AS, Plazas JG. SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022). Clin Transl Oncol. 2023 Sep;25(9):2692-2706. doi: 10.1007/s12094-023-03205-6. Epub 2023 May 19. PubMed PMID: 37204633; PubMed Central PMCID: PMC10425298.
AÑO: 2023; IF: 2.8
|
|
Sanchez-Canovas M, Jimenez-Fonseca P, Fernandez Garay D, Cejuela Solis M, Casado Elia D, Coma Salvans E, de la Haba Vacas I, Gomez Sanchez D, Fernandez Montes A, Morales Gimenez R, Biosca Gomez de Tejada M, Arrazubi Arrula V, Sequero Lopez S, Otero Candelera R, Sanchez Cendra C, Justo de la Pena M, Moreno Munoz D, Orillo Sarmiento M, Martinez de Castro E, Garcia Escobar I, Bernal Vidal A, Ortega Moran L, Munoz Martin AJ, Sanchez Bayona R, Martinez Ortiz MJ, Ayala de la Pena F, Vicente V, Carmona-Bayonas A. Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study. PLoS One. 2023 May 9;18(5):e0266305. doi: 10.1371/journal.pone.0266305. eCollection 2023. PubMed PMID: 37159465; PubMed Central PMCID: PMC10168567.
AÑO: 2023; IF: 2.9
|